Business Context and Reporting Period
This Form 8-K Current Report was filed by Synaptogenix, Inc. (not TAO Synergies Inc.) on April 8, 2021, regarding events occurring on April 7, 2021. The registrant is a Delaware corporation and an emerging growth company. The report details the results of a Special Meeting of stockholders held to vote on corporate governance and equity plan amendments.
Key Financial Metrics
This filing is a current report regarding corporate actions and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes and Voting Results
At the Special Meeting, approximately 70.78% of outstanding shares (9,931,549 shares) were present or represented by proxy. Stockholders approved three key proposals:
- Reverse Stock Split Authorization: The Board was authorized to effect a reverse stock split at any ratio between 1-for-1.5 and 1-for-20 before December 31, 2022.
- Votes For: 9,038,788
- Votes Against: 886,496
- Abstentions: 6,264
- Equity Incentive Plan Amendment: The 2020 Equity Incentive Plan was amended to increase the authorized share pool from 1,000,000 to 2,500,000 shares of Common Stock.
- Votes For: 7,678,240
- Votes Against: 314,493
- Abstentions: 42,674
- Adjournment Authority: Stockholders approved the ability to adjourn the meeting to solicit additional proxies if necessary.
- Votes For: 9,075,806
- Votes Against: 818,051
- Abstentions: 37,691
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the standard incorporation of the Definitive Proxy Statement. The primary operational change is the potential dilution impact from the increased equity pool and the potential reduction in share count via the authorized reverse stock split.
Investor Verification Checklist
- Verify the exact reverse stock split ratio and implementation date, as the Board retains discretion to act before December 31, 2022.
- Review the full text of the amended 2020 Equity Incentive Plan (Exhibit 10.1) to understand vesting schedules and eligibility for the additional 1.5 million shares.
- Confirm the current outstanding share count to assess the immediate impact of the approved equity plan expansion.
- Check subsequent filings to determine if the reverse stock split has been executed.